METTL3-mediated m6A modification of pri-miRNA-31 promotes hypertrophic scar progression
Authors:
Open Access
- 18 March 2025
- journal article
- Published by China Science Publishing & Media Ltd. in Acta Biochimica et Biophysica Sinica
- Vol. 57 (7) , 1106-1114
Abstract
Hypertrophic scar (HS) is a pathological scar characterized by excessive dermal fibrosis. Aberrant m6A modification patterns have been identified in HS; however, the expression of the methyltransferase, along with its function and molecular mechanisms in HS, remains unclear. In this study, we find that both the protein level of METTL3 and the level of m6A methylation are upregulated in HS compared with normal skin. To investigate the role of METTL3 in HS, we knock down METTL3 in HS-derived fibroblasts (HSFBs) via shRNA. METTL3 knockdown reduces the expressions of collagen types I and III (COL I/III) and α-SMA, inhibits cell proliferation and migration, and induces cell cycle arrest in the G1 phase. MeRIP-seq analysis reveals m6A modification sites on pri-miR-31. Our data indicate that the expression level of pri-miR-31 is elevated in METTL3-knockdown HSFBs, whereas the level of mature miR-31-5p is reduced. Notably, transfection of a miR-31-5p mimic into HSFBs partially counteracts the inhibitory effects of the m6A methylation inhibitors cycloleucine and STM2457 (a specific inhibitor of METTL3) on fibrosis and cellular proliferation. Additionally, we confirm that ZBTB20 is a downstream target of miR-31-5p and that knockdown of ZBTB20 inhibits fibroblast fibrosis. Collectively, our findings elucidate the epigenetic mechanism of METTL3/m6A/pri-miR-31/ZBTB20 in HS fibrosis, providing a potential therapeutic target for HS.Keywords
This publication has 23 references indexed in Scilit:
- Biological Effects of CYP11A1-Derived Vitamin D and Lumisterol Metabolites in the SkinJournal of Investigative Dermatology, 2024
- METTL14-mediated N6-methyladenosine modification of Col17a1/Itgα6/Itgβ4 governs epidermal homeostasisJournal of Dermatological Science, 2023
- METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent mannerExperimental & Molecular Medicine, 2021
- METTL3 mediated m6A modification plays an oncogenic role in cutaneous squamous cell carcinoma by regulating ΔNp63Biochemical and Biophysical Research Communications, 2019
- Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanismExperimental Cell Research, 2017
- Keloids and Hypertrophic Scars: A Spectrum of Clinical ChallengesAmerican Journal of Clinical Dermatology, 2016
- N6-methyladenosine marks primary microRNAs for processingNature, 2015
- Aberrant Regulation and Function of MicroRNAs in CancerCurrent Biology, 2014
- Diagnostic, functional, and therapeutic roles of microRNA in allergic diseasesJournal of Allergy and Clinical Immunology, 2013
- Transcriptome-wide mapping of N6-methyladenosine by m6A-seq based on immunocapturing and massively parallel sequencingNature Protocols, 2013